市場調查報告書

Amitriptyline市場全球市場 - 含有量·各適應症·各流通管道·各地區:市場規模·佔有率·未來展望·機會分析

Amitriptyline Market, By Strength, By Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968771
出版日期 內容資訊 英文 178 Pages
商品交期: 2-3個工作天內
價格
Amitriptyline市場全球市場 - 含有量·各適應症·各流通管道·各地區:市場規模·佔有率·未來展望·機會分析 Amitriptyline Market, By Strength, By Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年10月08日內容資訊: 英文 178 Pages
簡介

本報告提供全球Amitriptyline的市場相關分析,提供產品概要和相關疾病,市場基本結構及促進·阻礙因素,整體市場規模預測 (以金額為準,過去4年·今後8年份),含有量·各適應症·各流通管道·各地區的詳細趨勢,主要企業的簡介·業績·策略計劃等調查。

目錄

第1章 分析目的·前提條件

第2章 市場概要

  • 分析概要
    • 市場定義和範圍
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場力學·規定·趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 影響度分析
    • 市場機會
  • 事業聯盟·企業收購
  • 法規方案

第4章 全球Amitriptyline市場,COVID-19感染擴大的影響

  • COVID-19流行中的影響
  • COVID-19後的影響
  • 各國政府的對策
  • 對醫療產業的整體影響

第5章 全球Amitriptyline市場:含有量

  • 簡介
  • 市場佔有率分析:含有量 (最新值·預測值)
  • 與前一年同期相比成長率 (YoY) 分析:含有量 (實際成果值·預測值)
  • 各市場區隔趨勢
    • 10mg錠劑
      • 簡介
      • 市場規模與其預測,與前一年同期相比成長率 (YoY) (以金額為準)
    • 25mg錠劑
    • 50mg錠劑
    • 75mg錠劑
    • 100mg錠劑
    • 150mg錠劑

第6章 全球Amitriptyline市場:各適應症

  • 各市場區隔趨勢
    • 憂鬱症
    • 遺尿症
    • 偏頭痛
    • 慢性神經病變性疼痛
    • 其他

第7章 全球Amitriptyline市場:各流通管道

  • 各市場區隔趨勢
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第8章 全球Amitriptyline市場:各地區

  • 簡介
  • 北美
    • 簡介
    • 市場規模與其預測:各含有量
    • 市場規模與其預測:各適應症
    • 市場規模與其預測:各流通管道
    • 市場規模與其預測:各國
    • 美國
    • 加拿大
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美各國
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他的歐洲各國
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 東南亞國協
    • 其他的亞太地區各國
  • 中東
    • 波灣合作理事會 (GCC) 各國
    • 以色列
    • 其他的中東各國
  • 非洲
    • 北部非洲
    • 中部非洲
    • 非洲南部

第9章 競爭情形

  • 企業簡介
  • Accord Healthcare Inc.
  • Mylan Pharmaceuticals Inc.
  • Sandoz Inc.
  • Sun Pharmaceutical Industries Inc.
  • Vintage Pharmaceuticals Inc.
  • Zydus Pharmaceuticals USA Inc.
  • Watson laboratories Inc.
  • Torrent Pharmaceuticals Ltd.
目錄

Title:
Amitriptyline Market, By Strength (10 mg tablets, 25 mg tablets, 50 mg tablets, 75 mg tablets, 100 mg tablets, and 150 mg tablets), By Indication (Depression, Nocturnal Enuresis, Migraine, Chronic Neuropathic Pain, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Amitriptyline is a tricyclic antidepressant with sedative effects. Amitriptyline affects certain chemical messengers (neurotransmitters) that communicate between brain cells and help to regulate the mood. The drug is indicated for treatment of major depressive disorder, neuropathic pain, the prophylactic treatment of chronic tension type headache (CTTH) and migraine in adults, also used in the treatment of nocturnal enuresis. It is available in tablet form.

Market Dynamics

Increasing prevalence of depression or bipolar disorder is expected to drive demand for tricyclic antidepressants such as Amitriptyline, thereby contributing to growth of the global amitriptyline market. According to the Global Burden of Disease Collaborative Network, in 2017, the prevalence of bipolar disorder ranged from 0.3% to 1.2% by country, and around 46 million people suffered from the bipolar disorder worldwide. Bipolar disorder is a brain disorder, also known as manic illness, which affects the mood, energy level, and other activities.

Key features of the study:

  • This report provides in-depth analysis of the global amitriptyline market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global amitriptyline market based on the following parameters - company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Accord Healthcare Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Sun Pharmaceutical Industries Inc., Vintage Pharmaceuticals Inc., Zydus Pharmaceuticals USA Inc., Watson laboratories Inc., and Torrent Pharmaceuticals Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global amitriptyline market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurofibromatosis treatment drugs market.

Detailed Segmentation:

  • Global Amitriptyline Market, By Strength:
    • 10 mg tablets
    • 25 mg tablets
    • 50 mg tablets
    • 75 mg tablets
    • 100 mg tablets
    • 150 mg tablets
  • Global Amitriptyline Market, By Indication:
    • Depression
    • Nocturnal Enuresis
    • Migraine
    • Chronic Neuropathic Pain
    • Others
  • Global Amitriptyline Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Amitriptyline Market, By Region:
    • North America
      • By Strength:
      • 10 mg tablets
      • 25 mg tablets
      • 50 mg tablets
      • 75 mg tablets
      • 100 mg tablets
      • 150 mg tablets
      • By Indication:
      • Depression
      • Nocturnal Enuresis
      • Migraine
      • Chronic Neuropathic Pain
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Strength:
      • 10 mg tablets
      • 25 mg tablets
      • 50 mg tablets
      • 75 mg tablets
      • 100 mg tablets
      • 150 mg tablets
      • By Indication:
      • Depression
      • Nocturnal Enuresis
      • Migraine
      • Chronic Neuropathic Pain
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Strength:
      • 10 mg tablets
      • 25 mg tablets
      • 50 mg tablets
      • 75 mg tablets
      • 100 mg tablets
      • 150 mg tablets
      • By Indication:
      • Depression
      • Nocturnal Enuresis
      • Migraine
      • Chronic Neuropathic Pain
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Strength:
      • 10 mg tablets
      • 25 mg tablets
      • 50 mg tablets
      • 75 mg tablets
      • 100 mg tablets
      • 150 mg tablets
      • By Indication:
      • Depression
      • Nocturnal Enuresis
      • Migraine
      • Chronic Neuropathic Pain
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Strength:
      • 10 mg tablets
      • 25 mg tablets
      • 50 mg tablets
      • 75 mg tablets
      • 100 mg tablets
      • 150 mg tablets
      • By Indication:
      • Depression
      • Nocturnal Enuresis
      • Migraine
      • Chronic Neuropathic Pain
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Strength:
      • 10 mg tablets
      • 25 mg tablets
      • 50 mg tablets
      • 75 mg tablets
      • 100 mg tablets
      • 150 mg tablets
      • By Indication:
      • Depression
      • Nocturnal Enuresis
      • Migraine
      • Chronic Neuropathic Pain
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Accord Healthcare Inc.*
      • Company Overview
      • Strength Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Mylan Pharmaceuticals Inc.
    • Sandoz Inc.
    • Sun Pharmaceutical Industries Inc.
    • Vintage Pharmaceuticals Inc.
    • Zydus Pharmaceuticals USA Inc.
    • Watson laboratories Inc.
    • Torrent Pharmaceuticals Ltd.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Strength
  • Market Snippet, By Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Impact Analysis
  • Market Opportunities
  • Collaborations and Acquisition
  • Regulatory Scenario

4. Global Amitriptyline Market, Impact of COVID-19 Pandemic

  • During COVID-19 Impact
  • Post COVID-19 Impact
  • Government Initiatives
  • Overall Impact On the Healthcare Industry

5. Global Amitriptyline Market, By Strength, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • 10 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • 25 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • 50 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • 75 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • 100 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • 150 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

6. Global Amitriptyline Market, By Indication, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Nocturnal Enuresis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Migraine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Chronic Neuropathic Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

7. Global Amitriptyline Market, By Distribution Channel, 2020 - 2027, (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017- 2027
  • Segment Trends
    • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
    • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
    • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)

8. Global Amitriptyline Market, By Region, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Strength, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Indication, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel , 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Strength, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Indication, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Strength, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Indication, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Strength, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Indication, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Strength, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Indication, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Strength, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Indication, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016-2027 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
  • Accord Healthcare Inc.*
  • Company Overview
  • Strength Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Mylan Pharmaceuticals Inc.
  • Company Overview
  • Strength Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Sandoz Inc.
  • Company Overview
  • Strength Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Sun Pharmaceutical Industries Inc.
  • Company Overview
  • Strength Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Vintage Pharmaceuticals Inc.
  • Company Overview
  • Strength Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Zydus Pharmaceuticals USA Inc.
  • Company Overview
  • Strength Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Watson laboratories Inc.
  • Company Overview
  • Strength Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Torrent Pharmaceuticals Ltd.
  • Company Overview
  • Strength Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies